Huet Emilie, Boulay François, Barral Sophie, Rabiet Marie-Josèphe
Commissariat à l'Energie Atomique (CEA), DSV, iRSTV, Laboratoire de Biochimie et de Biophysique des Systèmes Intégrés (LBBSI), Grenoble, F-38054, France.
Cell Signal. 2007 Sep;19(9):1939-48. doi: 10.1016/j.cellsig.2007.05.006. Epub 2007 May 29.
The N-formyl peptide receptor-like 1 (FPRL1) is a G protein-coupled receptor (GPCR) that transmits intracellular signals in response to a variety of agonists, many of them being clearly implicated in human pathology. beta-arrestins are adaptor proteins that uncouple GPCRs from G protein and regulate receptor internalization. They can also function as signal transducers through the scaffolding of signaling molecules, such as components of the extracellular signal-regulated kinase (ERK) cascade. We investigated the role of beta-arrestins in ligand-induced FPRL1 internalization and signaling. In HEK293 cells expressing FPRL1, fluorescence microscopy revealed that agonist-stimulated FPRL1 remained co-localized with beta-arrestins during endocytosis. Internalization of FPRL1, expressed in a mouse embryonic fibroblast (MEF) cell line lacking endogenous beta-arrestins, was highly compromised. This distinguishes FPRL1 from the prototypical formyl peptide receptor FPR that is efficiently internalized in the absence of beta-arrestins. In both HEK293 and MEF cells, FPRL1-mediated ERK1/2 activation was a rapid and transient event. The kinetics and extent of ERK1/2 activation were not significantly modified by beta-arrestin overexpression. The pattern of FPRL1-mediated ERK1/2 activation was similar whether cells express or not beta-arrestins. Furthermore, treatment of the FPRL1 expressing cells with pertussis toxin inhibited ERK1/2 activation in MEF and in HEK293 cells. These results led us to conclude that activation of ERK1/2 mediated by FPRL1 occurs primarily through G protein signaling. Since beta-arrestin-mediated signaling has been observed essentially for receptors coupled to G proteins other than G(i), this may be a characteristic of G(i) protein-coupled chemoattractant receptors.
N-甲酰肽受体样1(FPRL1)是一种G蛋白偶联受体(GPCR),可响应多种激动剂传递细胞内信号,其中许多激动剂显然与人类病理学有关。β-抑制蛋白是一种衔接蛋白,可使GPCR与G蛋白解偶联并调节受体内化。它们还可以通过细胞外信号调节激酶(ERK)级联反应等信号分子的支架作用作为信号转导分子发挥功能。我们研究了β-抑制蛋白在配体诱导的FPRL1内化和信号传导中的作用。在表达FPRL1的HEK293细胞中,荧光显微镜显示激动剂刺激的FPRL1在胞吞作用期间仍与β-抑制蛋白共定位。在缺乏内源性β-抑制蛋白的小鼠胚胎成纤维细胞(MEF)细胞系中表达的FPRL1的内化受到严重损害。这将FPRL1与原型甲酰肽受体FPR区分开来,后者在没有β-抑制蛋白的情况下能有效地内化。在HEK293和MEF细胞中,FPRL1介导的ERK1/2激活都是快速且短暂的事件。β-抑制蛋白过表达并未显著改变ERK1/2激活的动力学和程度。无论细胞是否表达β-抑制蛋白,FPRL1介导的ERK1/2激活模式都是相似的。此外,用百日咳毒素处理表达FPRL1的细胞可抑制MEF和HEK293细胞中的ERK1/2激活。这些结果使我们得出结论,FPRL1介导的ERK1/2激活主要通过G蛋白信号传导发生。由于基本上已观察到β-抑制蛋白介导的信号传导是针对与G(i)以外的G蛋白偶联的受体,这可能是G(i)蛋白偶联趋化因子受体的一个特征。